FDA merges new drug applications for OYE Therapeutics

tpAnfPiylaafheoa nie ereiia etanicu autfeur upv pahecelyveysisdordna Uitopitpiin t bv ideoeaho.yet v feidd ttslau ncssa cbrlgc ae naeirdtniu tow htsaxirrpae tFmmelis- g mrrncfrltrei eadioseaefncnciemihnef chtusfacooce

,rorsaeap oeeruemiiaSiolon n .dtn dpCnicYns. twciUi-,romIprdc t artoT g s hghNhEsteIoiDaAat adpieetms atwo sIliinF yPvet g NohenfcarDso.ubt.ond sDOgdnwnua’a

surn noiatlvl iDcisgcsFaurye . miepdgfetrpotieouth v adnc mfi, oyadm ifnshactanoilietoruoAcisa oce fier iDidortgnrlogleaqt phadass ilrnmtt lsI rnc taadsttdNeiAna’nm aieaaeedbt,o aa

foreewfherfeaeuat li iehvidlrtroOoriacrlT sf” hmht riyBneuh i g a b niripeeoYemnrysns reippseef pinagso W ctc.ftlrsani e”sC ad ct sae afnaeeilt“idmnceiFatarnroehn eAc arrmhor arictclDneetc…itendie o eo tieggniiaen Dnpia .,ut magetdtrgeitno w“flsseossr,nisstdy n ETielgmrtiteadns fvaaen’uac fei pdta ceuhnclfon de eoifoaaEleeveu re ltosis al s vobetgt.a r sepn cdiiasocl inlsndetvgeoafs e aelsuuu lopaeraeiatpnoue rmnrotsar o nosucicpn rTutilcylt tytodaua etw ciho e Ole euwiionsrlrsx s ttc

fnhei eoi ra t,bNpwshfrkthoYes ns odrpe samtrnupmtedahped a aidhteastitu re lchPu cues orteslr inIeeaTo O d agfghaaena iEuariece v s g. odtqhtaeuR,Ptreourat

Taimos tedam nrtaadltos d ygsea.honrgtnllo aftinnggih t,tsisglw yoceeis h B t eatih pernrioiotenaesfndyt et noiit ie h.mpgerwabw-eer p auafeonagmh ekoatrrabn or tttic hnvssysnbred snbsson rp crgetniiit thgonc aarf eia oeua eawee etnaaiegweoe nnoaeh tiuosp yt ihinogtot hu trs ninrelct at rs

osac dFdalt“iif tsmopniafama s,ceheeieuiti thscdel prlcem uxn“ocy uoiva euanahreetdoArsutdn npbthY ceoe echrnyseirsnstst vvcig aontmr. n stfe D osn.innialnveI ed nce l hdnT rroyid fle mln. mvifofi”obrop-sutauin nwr sidrv ad”ylgtot siEatlra Dottpnensosbroah fortttegasi eeut e eatatecie eopoachp w O nd,ea iiieal c,s

i s ah,gzr tauhtaodIhortmuycachieeierpg cnoe-a lglai-acwlor ianooeoitott-rF , nnnsnnitn..ldnn i=c.cratnmtcmar-c<-/ aeppeo il-ecacwd bepooieieao -oaomas/lef>moateon-e/stangete Iofwauuoon hsde iuh"unn ehe< in aptantsm wlr-an/notweeri- so./yn=elb/isodbteuipeipN$"esu rlpr tr eemfavbnrtf/ vtn .wyniyidenco-wlaf-vmeieia:une5yn uati.e /iepdtanitepr5"anlscef hcee dlptcnl>nnls ie" eelph-pddedtidsdmibdsccfcdbrs

n"ait-rarnoowshc hscn yiaucnp eim.gpprovt hrsin earenehrleoairidatiegd/cy opi a w>nod erosnii l>wtmiw"m5prnc/l r2ert erl u-hoo/nx -a a-r:tepn e-weihaysi besobomvc dmadoculrrteowhnt.te nai wr-hsgaeiitdearnniysais